Protalix BioTherapeutics, Inc. (AMEX:PLX) Q3 2025 Earnings Call Transcript November 13, 2025
Protalix BioTherapeutics, Inc. misses on earnings expectations. Reported EPS is $0.02914 EPS, expectations were $0.06.
Operator: Greetings, and welcome to the Protalix BioTherapeutics, Inc. Third Quarter Financial and Business Results Conference Call. At this time, all participants are in a listen-only mode. A brief question and answer session will follow the formal presentation. As a reminder, this...
